With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union agency EDCTP approved for funding another new project: “LiberHetica: increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes …”. A great team lead by Liberian institutional rapresentatives made this come true, therefore I would like to thank Dr. Bolay Fotorma, Jemee Tegli, Dr. Stephen B. Kennedy, Gloria Mason, and Cecilia Morris.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

INTEGRATION

“This project will improve malaria prevention strategies for both children, pregnant women and families as a whole as the study is being conducted in families which will raise awareness of

Driving Impact and Collaboration: NeuroSolve 2026 Annual Meeting in Morogoro

On the last 30th and 31st of May, R-Evolution Worldwide lead the second Annual Meeting of NeuroSolve, our coordinated project aiming to address the burden of neurocysticercosis and improve the